May 15, 2017, Egypt
Orchidia Pharmaceutical Industries has begun the introduction of Bromoflam in the Egyptian market through Hospitals and Pharmacies.
Bromoflam is a product containing Bromfenac Sodium in a 5 ml eye drop; it is an anti-inflammatory, non-steroidal eye drop characterized by its efficacy in the treatment of pain associated with surgery and eye inflammation pain.
Bromoflam is the first and only eye product in Egypt to contain the active ingredient Bromfenac Sodium.
Orchidia plans to make the Bromoflam the market leader of the as anti-inflammatory non-steroidal eye drops market in Egypt during the coming two years.
Bromoflam is priced at 25 Egyptian pounds for the public.